ProductNum | picture | CAS No. | Name and description | Formula | Quick order |
---|---|---|---|---|---|
CLA1648 |
|
267639-76-9 |
Romiplostim | Ropstine 98+% |
C15H14N2O | |
CLA1653 |
|
1446419-85-7 |
Anti-Human ANGPTL3 Monoclonal Antibody(Evinacumab) 95+% |
||
CLA1188 |
|
914613-48-2 |
Anti-Human IL-1B Monoclonal Antibody(Canakinumab) 95+% |
— | |
CLA1031 |
|
347396-82-1 |
Ranibizumab (Anti-VEGFA) 95+% |
— | |
CLA1032 |
|
339186-68-4 |
Matuzumab 95+% |
— | |
CLA1023 |
|
375823-41-9 |
Tocilizumab (anti-IL-6R); MRA 95+% |
— | |
CLA1015 |
|
219685-50-4 |
Eculizumab 95+% |
— | |
CLA1012 |
|
615258-40-7 |
Denosumab (anti-RANK ligand) | AMG-162 95+% |
— | |
CLA1008 |
|
216974-75-3 |
Bevacizumab (anti-VEGF) ; rhuMab VEGF 95+% |
— | |
CLA1006 |
|
331731-18-1 |
Adalimumab (anti-TNF-alpha) 95+% |
— | |
CLA1002 |
|
946414-94-4 |
Nivolumab (anti-PD-1) 95+% |
— | |
CLA1057 |
|
143090-92-0 |
Anakinra (IL-1Ra) | Raleukin | AMG-719 98+% |
C759H1186N208O232S10 | |
CLA1009 |
|
174722-31-7 |
Anti-CD20 (rituximab biosimilar) mAb 95+% |
— | |
CLA1005 |
|
205923-56-4 |
Cetuximab(C225),Stock solution 95+% |
C6484H10042N1732O2023S36 | |
CLA1003 |
|
180288-69-1 |
Trastuzumab (anti-HER2) 95+% |
C6470H10012N1726O2013S42 | |